Inhibitors of cyclin-dependent kinases
US11358958B2 · kind B2 · utility
0Cited by
3References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 11, 2020 |
| Grant date | Jun 14, 2022 |
| Priority date | — |
| Expiry date | Nov 11, 2040 |
Classification
- Technology area (CPC —)General
Abstract
Provided herein are inhibitors of cyclin-dependent kinases (CDKs), pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.